Operating Segments (Tables)

12 Months Ended

Sep. 30, 2012

Operating Segments [Abstract]

Schedule of segment revenue operating income from continuing operations and depreciation and amortization

	2012			2011			2010
Revenue:
Medical Device	$	37,883		$	39,606		$	43,294
In Vitro Diagnostics		14,045			13,150			11,194
Total revenue	$	51,928		$	52,756		$	54,488
Operating income (loss):
Medical Device	$	18,431		$	19,997		$	19,461
In Vitro Diagnostics		4,542			4,314			3,296
Corporate		(6,631	)		(8,788	)		(10,766	)
Total operating income from continuing operations	$	16,342		$	15,523		$	11,991
Depreciation and amortization:
Medical Device	$	1,414		$	1,604		$	2,136
In Vitro Diagnostics		774			799			828
Corporate		741			756			656
Total depreciation and amortization	$	2,929		$	3,159		$	3,620

Revenue from major customers

	2012			2011			2010
Medtronic		19	%		18	%		16	%
Johnson & Johnson		**			16	%		22	%

** -less than 10%

Geographic revenue

	2012			2011			2010
Domestic		79	%		73	%		79	%
Foreign		21	%		27	%		21	%